EA201400131A1 - Новый классификатор для молекулярной классификации миеломной болезни - Google Patents

Новый классификатор для молекулярной классификации миеломной болезни

Info

Publication number
EA201400131A1
EA201400131A1 EA201400131A EA201400131A EA201400131A1 EA 201400131 A1 EA201400131 A1 EA 201400131A1 EA 201400131 A EA201400131 A EA 201400131A EA 201400131 A EA201400131 A EA 201400131A EA 201400131 A1 EA201400131 A1 EA 201400131A1
Authority
EA
Eurasian Patent Office
Prior art keywords
multiple myeloma
molecular classification
new classifier
myeloid disease
disease
Prior art date
Application number
EA201400131A
Other languages
English (en)
Other versions
EA032730B1 (ru
Inventor
Рован Кёйпер
Питер Сонневельд
Original Assignee
Эразмус Юниверсити Медикал Сентер Роттердам
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эразмус Юниверсити Медикал Сентер Роттердам filed Critical Эразмус Юниверсити Медикал Сентер Роттердам
Publication of EA201400131A1 publication Critical patent/EA201400131A1/ru
Publication of EA032730B1 publication Critical patent/EA032730B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Настоящее изобретение в области молекулярной диагностики и относится к способам классификации образцов, полученных от больных с диагнозом миеломная болезнь, в три впервые определённых кластера. Изобретение также относится к способам определения прогноза индивидуального диагноза миеломной болезни, так же как способ предсказания ответа на лечение индивидуального диагноза миеломной болезни. Более подробно, изобретение обеспечивает способ определения исхода болезни или прогноза у больного с диагнозом миеломная болезнь путём классификации упомянутого больного в категорию высокого риска или низкого риска, на основе 92-генного классификатора.
EA201400131A 2011-07-14 2012-07-12 Способ прогнозирования исхода болезни у пациента с диагнозом множественной миеломы EA032730B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11173971A EP2546357A1 (en) 2011-07-14 2011-07-14 A new classifier for the molecular classification of multiple myeloma.
PCT/EP2012/063722 WO2013007795A1 (en) 2011-07-14 2012-07-12 A new classifier for the molecular classification of multiple myeloma

Publications (2)

Publication Number Publication Date
EA201400131A1 true EA201400131A1 (ru) 2014-04-30
EA032730B1 EA032730B1 (ru) 2019-07-31

Family

ID=46506441

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400131A EA032730B1 (ru) 2011-07-14 2012-07-12 Способ прогнозирования исхода болезни у пациента с диагнозом множественной миеломы

Country Status (18)

Country Link
US (3) US9976185B2 (ru)
EP (2) EP2546357A1 (ru)
JP (1) JP6026529B2 (ru)
KR (1) KR101933742B1 (ru)
AU (1) AU2012282437B2 (ru)
BR (1) BR112014000648B1 (ru)
CA (1) CA2841536C (ru)
CL (1) CL2014000103A1 (ru)
DK (1) DK2732048T3 (ru)
EA (1) EA032730B1 (ru)
ES (1) ES2633165T3 (ru)
IL (1) IL230164A (ru)
MX (1) MX346314B (ru)
NZ (1) NZ619896A (ru)
PL (1) PL2732048T3 (ru)
PT (1) PT2732048T (ru)
WO (1) WO2013007795A1 (ru)
ZA (1) ZA201400159B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2546357A1 (en) 2011-07-14 2013-01-16 Erasmus University Medical Center Rotterdam A new classifier for the molecular classification of multiple myeloma.
US20190383817A1 (en) * 2016-02-12 2019-12-19 Skylinedx B.V. Predicting response to immunomodulatory drugs (imids) in multiple myeloma patients
EP3607479A1 (en) 2017-04-04 2020-02-12 SkylineDx B.V. Method for identifying gene expression signatures
US10973820B2 (en) 2017-12-13 2021-04-13 Facio Intellectual Property B.V. Compounds for treatment of diseases related to DUX4 expression
US20210055301A1 (en) * 2018-04-28 2021-02-25 Beijing Normal University Molecular typing of multiple myeloma and application
CN110218789B (zh) * 2019-04-22 2022-10-04 曾文炳 一种用于预测多发性骨髓瘤患者总体生存率的基因探针组合物及试剂盒
TW202112368A (zh) 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合
JP2023503988A (ja) 2019-11-29 2023-02-01 ファシオ インテレクチュアル プロパティ ビー．ヴイ． Ｄｕｘ４発現に関連する疾患を処置するための新たな化合物
CA3159239A1 (en) 2019-11-29 2021-06-03 Pui Leng Loke Novel compounds for treatment of diseases related to dux4 expression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
JP2005512557A (ja) * 2001-11-07 2005-05-12 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ アーカンソー 遺伝子発現プロファイリングに基づく多発性骨髄腫の診断、予後、および治療標的候補の同定
US20080274911A1 (en) * 2006-11-07 2008-11-06 Burington Bart E Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereof
JP5531360B2 (ja) * 2006-11-07 2014-06-25 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ アーカンソー 遺伝子発現プロファイリングに基づく高リスク多発性骨髄腫のゲノムシグネチャーの特定とその使用
EP1964930A1 (en) * 2007-02-28 2008-09-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Molecular classifier for prognosis in multiple myeloma
WO2010064016A2 (en) * 2008-12-05 2010-06-10 The Institute Of Cancer Research: Royal Cancer Hospital Methods for determining a prognosis in multiple myeloma
WO2010151731A1 (en) * 2009-06-26 2010-12-29 University Of Utah Research Foundation Materials and methods for the identification of drug-resistant cancers and treatment of same
EP2546357A1 (en) 2011-07-14 2013-01-16 Erasmus University Medical Center Rotterdam A new classifier for the molecular classification of multiple myeloma.

Also Published As

Publication number Publication date
US9976185B2 (en) 2018-05-22
PT2732048T (pt) 2017-07-18
EP2546357A1 (en) 2013-01-16
MX346314B (es) 2017-03-15
NZ619896A (en) 2016-04-29
WO2013007795A1 (en) 2013-01-17
BR112014000648A2 (pt) 2017-02-14
MX2014000440A (es) 2014-07-09
EP2732048A1 (en) 2014-05-21
JP6026529B2 (ja) 2016-11-16
CL2014000103A1 (es) 2014-07-04
KR20140044364A (ko) 2014-04-14
ZA201400159B (en) 2017-09-27
US20180237866A1 (en) 2018-08-23
IL230164A (en) 2017-12-31
EP2732048B1 (en) 2017-05-10
ES2633165T3 (es) 2017-09-19
JP2014520540A (ja) 2014-08-25
BR112014000648B1 (pt) 2020-04-07
CA2841536C (en) 2020-09-22
AU2012282437A1 (en) 2014-01-23
US20140221313A1 (en) 2014-08-07
DK2732048T3 (en) 2017-08-07
KR101933742B1 (ko) 2018-12-28
US10815532B2 (en) 2020-10-27
AU2012282437B2 (en) 2016-04-21
EA032730B1 (ru) 2019-07-31
US20210010091A1 (en) 2021-01-14
PL2732048T3 (pl) 2017-10-31
CA2841536A1 (en) 2013-01-17

Similar Documents

Publication Publication Date Title
EA201400131A1 (ru) Новый классификатор для молекулярной классификации миеломной болезни
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
WO2016094330A3 (en) Methods and machine learning systems for predicting the liklihood or risk of having cancer
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
EA201391187A1 (ru) Способ диагностики злокачественной опухоли и набор для диагностики путем измерения активности nk-клеток
WO2013068374A3 (en) Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
BR112013010015A2 (pt) aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos
WO2013008102A3 (en) Methods and compositions for evaluating and/or treating chronic immune diseases
WO2013068373A3 (en) Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
MX2018009304A (es) Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares.
WO2012125807A3 (en) Systems and compositions for diagnosing barrett's esophagus and methods of using the same
CA2839777C (en) Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
EA201590024A1 (ru) Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток
BR112012014060A2 (pt) métodos e reagentes para detecção aprimorada de peptídeos beta-amiloides
WO2013181418A3 (en) Multiplexed diagnosis method for classical hodgkin lymphoma
MX356797B (es) Uso de anticuerpo anti-alfa-sinucleina para diagnosticar nivel elevado de alfa-sinucleina en el cerebro.
MX2017006075A (es) Biomarcadores para la progresion de enfermedades en melanoma.
AU2012339149A8 (en) Method for the diagnosis of Niemann-Pick disease
EA201691168A1 (ru) Способы исследования бета-глюкана
WO2014052685A3 (en) Devices and methods for single cell analysis
EA201390017A1 (ru) Молекулярно-генетический подход к лечению и диагностике алкогольной и наркотической зависимости
WO2015006657A8 (en) Method for the diagnosis and prognosis of cancer
WO2012045324A8 (en) Method for detecting a parkinson's disease and test system
RU2010123021A (ru) Способ диагностики рака молочной железы по уровню рнк интерлейкинов il-8 и/или il-18 в плазме крови
RU2014154144A (ru) Аутоиммунные антитела

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM